>

DIVIS Stock Today

<div class='circular--portrait' style='background:#FF9E01;color: white;font-size:3em;padding-top: 40px;;'>DIV</div>

Performance

1 / 100

Odds of Distress

Analyze Filter   Check how we calculate scores
Equity ratings for DIVIS LABORATORIE are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting January 1, 2020 and ending today March 31, 2020. Click here to learn more.

DIVIS LABORATORIE Profile

Divis Laboratories Limited manufactures and sells generic active pharmaceutical ingredients and intermediates for in the United States, Asia, Europe, and internationally. Divis Laboratories Limited was founded in 1990 and is headquartered in Hyderabad, India. DIVIS LABORATORIE operates under Drug ManufacturersSpecialty Generic classification in India and is traded on National Stock Exchange of India. more on DIVIS LABORATORIE
Legal NameDIVIS LABORATORIE
Thematic Classifications
Active investing themes DIVIS LABORATORIE currently participates. An investing theme is an unweighted collection of funds, stocks, ETFs or cryptocurrencies
    Drugs
    Healthcare
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Horizon: 30 days (very short)Advice
DIVIS LABORATORIE (DIVISLAB) is traded on National Stock Exchange of India in India and employs 5 people. The company currently falls under 'Mega-Cap' category with current market capitalization of 496.68 B. DIVIS LABORATORIE operates under Healthcare sector and is part of Drug Manufacturers?Specialty & Generic industry. The entity has 265.47 M outstanding shares. DIVI'S LABORATORI has accumulated about 5.77 B in cash with 7.96 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 21.74.
Check DIVIS LABORATORIE Probability Of Bankruptcy

DIVIS Stock Price Odds Analysis

Odds Down 1862.55HorizonTargetOdds Up 1862.55
29.76%30 days
 1,863 
70.07%
Based on normal probability distribution, the odds of DIVIS LABORATORIE to move above current price in 30 days from now is about 70.07 (This DIVIS LABORATORIE probability density function shows the probability of DIVIS LABORATORIE Stock to fall within a particular range of prices over 30 days) .

DIVIS Stock Top Holders

DIVIS LABORATORIE Risk Profiles

DIVIS Stock Against Markets

Did you try this?

Run Piotroski F Score Now

   

Piotroski F Score

Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
All  Next Launch Module

DIVIS LABORATORIE Distributions to stockholders

Continue to Investing Opportunities. Please also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page